Mostrar registro simples

dc.contributor.authorLutz, Bárbara Heatherpt_BR
dc.contributor.authorBassani, Diego Garciapt_BR
dc.contributor.authorMiranda, Vanessa Iribarrem Avenapt_BR
dc.contributor.authorSilveira, Marysabel Pinto Telispt_BR
dc.contributor.authorMengue, Sotero Serratept_BR
dc.contributor.authorDal Pizzol, Tatiane da Silvapt_BR
dc.contributor.authorSilveira, Mariângela Freitas dapt_BR
dc.contributor.authorBertoldi, Andréa Dâmasopt_BR
dc.date.accessioned2020-03-04T04:18:36Zpt_BR
dc.date.issued2020pt_BR
dc.identifier.issn1660-4601pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/206394pt_BR
dc.description.abstractBackground: This study describes medication use by women up to 3 months postpartum and evaluates the association between medication use by women who were still breastfeeding at 3 months postpartum and weaning at 6 and 12 months. Methods: Population-based cohort, including women who breastfed (n = 3988). Medications were classified according to Hale’s lactation risk categories and Brazilian Ministry of Health criteria. Duration of breastfeeding was analysed using Cox regression models and Kaplan-Meier curves, including only women who were still breastfeeding at three months postpartum. Results: Medication use with some risk for lactation was frequent (79.6% regarding Hale’s risk categories and 12.3% regarding Brazilian Ministry of Health criteria). We did not find statistically significant di erences for weaning at 6 or 12 months between the group who did not use medication or used only compatible medications and the group who used medications with some risk for lactation, according to both criteria. Conclusions: Our study found no association between weaning rates across the di erent breastfeeding safety categories of medications in women who were still breastfeeding at three months postpartum. Therefore, women who took medications and stopped breastfeeding in the first three months postpartum because of adverse side-e ects associated with medications could not be addressed in this analysis.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofInternational journal of environmental research and public health. Basel. Vol. 17, no. 2 (2020), 568, [16 p.]pt_BR
dc.rightsOpen Accessen
dc.subjectPharmacoepidemiologyen
dc.subjectFarmáciapt_BR
dc.subjectBreastfeedingen
dc.subjectFarmacoepidemiologiapt_BR
dc.subjectDrug utilizationen
dc.subjectAleitamento maternopt_BR
dc.subjectUso de medicamentospt_BR
dc.subjectPharmaceutical preparationsen
dc.subjectCohort studiesen
dc.subjectPreparações farmacêuticaspt_BR
dc.subjectEstudos de coortespt_BR
dc.subjectWeaningen
dc.subjectDesmamept_BR
dc.subjectRisk assessmenten
dc.subjectMedição de riscopt_BR
dc.titleUse of medications by breastfeeding women in the 2015 Pelotas (Brazil) birth cohort studypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001110843pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples